Ticker
ACHL

Price
0.84
Stock movement down
-0.04 (-4.55%)
Company name
Achilles Therapeutics PLC ADR
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
34.39M
Ent value
-120.77M
Price/Sales
-
Price/Book
0.17
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-73.42%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2023-03-22
The following slide deck was published by Achilles Therapeutics plc in conjunction with this event.
March 15, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
March 7, 2023

iO Charts is a Seeking Alpha partner

DIVIDENDS

ACHL does not pay dividends or no data was received
I believe that recent selling in ACHL is due to tax loss sellers needing to recognize capital loss before the end of the year. See why you should Buy.
December 18, 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
November 22, 2022

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book0.17
EV to Sales-
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
November 8, 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
August 9, 2022

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count40.94M
EPS (TTM)-1.66
FCF per share (TTM)-0.88

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)-74.01M
Net income (TTM)-65.35M
EPS (TTM)-1.66
EPS (1y forward)-1.85

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash179.89M
Net receivables10.71M
Total current assets198.69M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets227.35M
Accounts payable7.52M
Short/Current long term debt8.99M
Total current liabilities19.06M
Total liabilities24.73M
Shareholder's equity202.62M
Net tangible assets202.62M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-57.68M
Capital expenditures (TTM)5.46M
Free cash flow (TTM)-34.43M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-32.25%
Return on Assets-28.74%
Return on Invested Capital-31.62%
Cash Return on Invested Capital-16.66%
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
July 21, 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
May 10, 2022

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.88
Daily high0.93
Daily low0.83
Daily Volume391K
All-time high17.86
1y analyst estimate12.40
Beta-
EPS (TTM)-1.66
Dividend per share-
Ex-div date-
Next earnings date8 May 2023

Downside potential

Loading...
Downside potential data
ACHLS&P500
Current price drop from All-time high-95.30%-17.92%
Highest price drop-95.58%-56.47%
Date of highest drop22 Dec 20229 Mar 2009
Avg drop from high-73.10%-11.51%
Avg time to new high249 days13 days
Max time to new high495 days1805 days
The following slide deck was published by Achilles Therapeutics plc in conjunction with this event.
April 29, 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
March 1, 2022

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ACHL (Achilles Therapeutics PLC ADR) company logo
Marketcap
34.39M
Marketcap category
Small-cap
Description
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. The company was founded in 2016 and is headquartered in London, the United Kingdom.
Employees
242
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
January 13, 2022

iO Charts is a Seeking Alpha partner

Achilles Therapeutics plc (NASDAQ:NASDAQ:ACHL) SITC & Corporate Update Call November 12, 2021 8:30 AM ETCompany ParticipantsLee Stern - VP, IR & External CommunicationsIraj Ali -...
November 13, 2021

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
November 10, 2021

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
November 9, 2021

iO Charts is a Seeking Alpha partner

COMPANY NEWS
All newsPress releases
- Demonstrated early proof-of-concept for cNeT therapy in heavily pre-treated advanced NSCLC patients - - Exhibited power of translational science platform by correlating anti-tumor activity of cNeT w...
March 7, 2023
Here is how Achilles Therapeutics PLC Sponsored ADR (ACHL) and Geron (GERN) have performed compared to their sector so far this year.
February 2, 2023
Here is how Anika Therapeutics (ANIK) and Achilles Therapeutics PLC Sponsored ADR (ACHL) have performed compared to their sector so far this year.
January 17, 2023
LONDON, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, t...
December 20, 2022
- Early proof-of-concept data support durable clinical benefit including confirmed partial response and stable disease in heavily pre-treated patients with advanced NSCLC - - Safety and tolerability p...
December 6, 2022
- Durable partial response (PR) and stable disease (SD) achieved in heavily pre-treated non-small cell lung cancer (NSCLC) patients dosed with cNeT monotherapy - - Updated interim Phase I/II results s...
November 30, 2022
- US patent is for an immunotherapy targeting clonal neoantigens identified by the Achilles Clonality Engine (ACE), including vaccine, antibody, and autologous T cell therapy approaches -LONDON, Nov. ...
November 22, 2022
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
November 13, 2022
- Interim update from the ongoing Phase I/IIa trials in advanced NSCLC (CHIRON) and melanoma (THETIS) to be presented at the ESMO Immuno-Oncology Annual Congress 2022 - - Strong cash balance of $179.9...
November 8, 2022
Achilles Therapeutics PLC Sponsored ADR (ACHL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the ...
November 1, 2022
Next page
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
October 22, 2021

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
August 25, 2021

iO Charts is a Seeking Alpha partner